Furthermore, in a study targeting patients with IBD, a link between a genetic variant of SCN10A, a gene coding Nav1.8, and abdominal pain perception was found.96 These previous studies demonstrate that targeting specific VSCGs could be a pathway for improving the diagnostic and therapeutic management of chronic abdominal pain in IBD patients. Here, SCN10A is linked to irritable bowel syndrome.